Alpha Teknova Statistics
NASDAQ: TKNOHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
8.71-0.04 (-0.46%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Alpha Teknova by the numbers
Alpha Teknova has a market capitalization of $467.6 million based on 53.69M shares outstanding. With trailing EPS of $-0.31, Alpha Teknova is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.6% above its 50-day average and 90.2% above its 200-day average.
Average daily trading volume is 232.52K shares, or about $2.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TKNO valuation vs. peer median
| Metric | TKNO | Peer median | Difference |
|---|---|---|---|
| Market cap | $467.62M | $164.15M | +185% |
| Avg. volume | 232.52K | 849.63K | -73% |
Peer median across 8 companies: MYGN, NNNN, ACHV, IMDX, QDEL, ICCC, BMRA, VNRX.
Valuation
- Market cap
- $467.62M
- EPS (TTM)
- $-0.31
- Shares outstanding
- 53.69M
Price and trading
- Previous close
- 8.75
- Open
- 8.62
- Day range
- 8.34 – 8.88
- 52-week range
- 1.91 – 9.48
- 52-week change
- +66.22%
- Beta
- —
- Volume
- 267.67K
- Average volume
- 232.52K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 467.62M
- Forward Pe
- -45.84
- Eps
- -0.31
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.48
- Week52 Low
- 1.91
- Avg Volume
- 232.52K
- Shares Outstanding
- 53.69M
- Ma50
- 7.28
- Ma200
- 4.58
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -8.12%
- Pct From52w Low
- 356.02%